WEKO3
アイテム
{"_buckets": {"deposit": "ba05ae72-0b7a-4172-bd36-36091612f3fc"}, "_deposit": {"id": "16372", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "16372"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00016372", "sets": ["456", "1103"]}, "item_7_alternative_title_1": {"attribute_name": "その他のタイトル", "attribute_value_mlt": [{"subitem_alternative_title": "Diabetic Neuropathy"}]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "1998-10", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "10", "bibliographicPageEnd": "610", "bibliographicPageStart": "607", "bibliographicVolumeNumber": "112", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Diabetic neuropathy is a common complication of diabetes and occurs in approximately 50-70 % of diabetic patients. The common presentation of diabetic neuropathy is chronic, symmetric distal sensory loss and hyporeflexia, which usually occurs in longstanding forms of either type of diabetes. The pathogenesis is multifactorial, such as changes in polyol pathway flux, oxidative stress, non-enzymatic protein glycation, endothelial dysfunction leading to reduced nerve blood flow and deficits in neurotrophic factors. Examination with magnetic resonance spectroscopy revealed that endoneurial edema initiates deterioration of physiological functions in nerve without clinical symptoms, followed by abnormal findings on neurological examination which meant reversibility of the neuropathy in early stages of the diabetic condition. Drugs that improve the nerve micro environment might be benificial in the early phase of neuropathy, whereas in the late stage, drugs that enhance nerve regeneration might restore neurological function.", "subitem_description_type": "Abstract"}]}, "item_7_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"nameIdentifiers": [{"nameIdentifier": "104354", "nameIdentifierScheme": "WEKO"}], "names": [{"name": "Tanaka, Keiko"}]}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "田中, 恵子"}], "nameIdentifiers": [{"nameIdentifier": "104353", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "112(10)_607-610.pdf", "filesize": [{"value": "701.6 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 701600.0, "url": {"label": "112(10)_607-610.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/16372/files/112(10)_607-610.pdf"}, "version_id": "6baba8a2-e2d5-4a54-84fa-4fd04f05d711"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "diabetic neuropathy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "autonomic neuropathy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "pathogenesis", "subitem_subject_scheme": "Other"}, {"subitem_subject": "pharmacotherapy", "subitem_subject_scheme": "Other"}, {"subitem_subject": "糖尿病性神経障害", "subitem_subject_scheme": "Other"}, {"subitem_subject": "自律神経障害", "subitem_subject_scheme": "Other"}, {"subitem_subject": "病因", "subitem_subject_scheme": "Other"}, {"subitem_subject": "治療", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "3)糖尿病性神経障害(シンポジウム 糖尿病合併症の治療, 第535回新潟医学会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "3)糖尿病性神経障害(シンポジウム 糖尿病合併症の治療, 第535回新潟医学会)"}, {"subitem_title": "3)糖尿病性神経障害(シンポジウム 糖尿病合併症の治療, 第535回新潟医学会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1103"], "permalink_uri": "http://hdl.handle.net/10191/46254", "pubdate": {"attribute_name": "公開日", "attribute_value": "2017-02-08"}, "publish_date": "2017-02-08", "publish_status": "0", "recid": "16372", "relation": {}, "relation_version_is_last": true, "title": ["3)糖尿病性神経障害(シンポジウム 糖尿病合併症の治療, 第535回新潟医学会)"], "weko_shared_id": null}
3)糖尿病性神経障害(シンポジウム 糖尿病合併症の治療, 第535回新潟医学会)
http://hdl.handle.net/10191/46254
http://hdl.handle.net/10191/46254b130501f-41c3-4cc1-81f9-cf9cc4cc2f66
名前 / ファイル | ライセンス | アクション |
---|---|---|
112(10)_607-610.pdf (701.6 kB)
|
|
Item type | 紀要論文 / Departmental Bulletin Paper(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-02-08 | |||||
タイトル | ||||||
タイトル | 3)糖尿病性神経障害(シンポジウム 糖尿病合併症の治療, 第535回新潟医学会) | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | 3)糖尿病性神経障害(シンポジウム 糖尿病合併症の治療, 第535回新潟医学会) | |||||
言語 | ||||||
言語 | jpn | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | diabetic neuropathy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | autonomic neuropathy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | pathogenesis | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | pharmacotherapy | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 糖尿病性神経障害 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 自律神経障害 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 病因 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | 治療 | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | departmental bulletin paper | |||||
その他のタイトル | ||||||
その他のタイトル | Diabetic Neuropathy | |||||
著者 |
田中, 恵子
× 田中, 恵子 |
|||||
著者別名 | ||||||
識別子 | 104354 | |||||
識別子Scheme | WEKO | |||||
姓名 | Tanaka, Keiko | |||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Diabetic neuropathy is a common complication of diabetes and occurs in approximately 50-70 % of diabetic patients. The common presentation of diabetic neuropathy is chronic, symmetric distal sensory loss and hyporeflexia, which usually occurs in longstanding forms of either type of diabetes. The pathogenesis is multifactorial, such as changes in polyol pathway flux, oxidative stress, non-enzymatic protein glycation, endothelial dysfunction leading to reduced nerve blood flow and deficits in neurotrophic factors. Examination with magnetic resonance spectroscopy revealed that endoneurial edema initiates deterioration of physiological functions in nerve without clinical symptoms, followed by abnormal findings on neurological examination which meant reversibility of the neuropathy in early stages of the diabetic condition. Drugs that improve the nerve micro environment might be benificial in the early phase of neuropathy, whereas in the late stage, drugs that enhance nerve regeneration might restore neurological function. | |||||
書誌情報 |
新潟医学会雑誌 en : 新潟医学会雑誌 巻 112, 号 10, p. 607-610, 発行日 1998-10 |
|||||
出版者 | ||||||
出版者 | 新潟医学会 | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00290440 | |||||
書誌レコードID | ||||||
収録物識別子タイプ | NCID | |||||
収録物識別子 | AN00182415 | |||||
著者版フラグ | ||||||
値 | publisher |